Status:
COMPLETED
Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer
Lead Sponsor:
University Hospital, Tours
Collaborating Sponsors:
Centre Régional de Coordination des Dépistages des Cancers - Centre-Val de Loire
Centre d'Investigation Clinique-P1415, TOURS
Conditions:
Cervical Cancer Screening
Cervical Cancer
Eligibility:
FEMALE
30-66 years
Phase:
NA
Brief Summary
Despite the existence of an effective screening test (pap smear), cervical cancer is, every year in France, the cause of more than 3,000 new cases and 1,100 deaths. But, in France, 4 in 10 women are n...
Eligibility Criteria
Inclusion
- women from 30 to 66 years old
- women living in french territorial division 37 ("Indre-et-Loire")
- women with a mobile phone in database
- women who do not perform a pap smear in the last 4 years
- women who do not answer to a first "invitation" letter to perform a pap smear
Exclusion
- STOP SMS
- HPV cervical pathology during treatment
- Hysterectomy including cervix
Key Trial Info
Start Date :
February 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2021
Estimated Enrollment :
10400 Patients enrolled
Trial Details
Trial ID
NCT03856684
Start Date
February 11 2020
End Date
October 20 2021
Last Update
October 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Crcdc-Cvl
Tours, France, 37044